Cargando…
Editorial: can China master the guideline challenge?
China is experiencing increased health care use and expenditures, without sufficient controls to ensure quality and value. Transparent, cost-conscious and patient-centered guidelines based on the best available evidence could help establishing these quality and practice measures. We examined how gui...
Autores principales: | Yang, Kehu, Chen, Yaolong, Li, Youping, Schünemann, Holger J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3544593/ https://www.ncbi.nlm.nih.gov/pubmed/23302417 http://dx.doi.org/10.1186/1478-4505-11-1 |
Ejemplares similares
-
Clinical practice guidelines in China
por: Chen, Yaolong, et al.
Publicado: (2018) -
Idiopathic pulmonary fibrosis – clinical management guided by the evidence-based GRADE approach: what arguments can be made against transparency in guideline development?
por: Rochwerg, Bram, et al.
Publicado: (2016) -
Clinical practice guidelines for COVID-19
por: Chen, Yaolong, et al.
Publicado: (2020) -
Development of rapid guidelines: 3. GIN-McMaster Guideline Development Checklist extension for rapid recommendations
por: Morgan, Rebecca L., et al.
Publicado: (2018) -
How a well-grounded minimal important difference can enhance transparency of labelling claims and improve interpretation of a patient reported outcome measure
por: Brożek, Jan L, et al.
Publicado: (2006)